Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications

References

• MuyldermansSNanobodies: natural single-domain antibodiesAnnu Rev Biochem20138277579723495938
   PubMed Web of Science ®Google Scholar
• De MeyerTMuyldermansSDepickerANanobody-based products as research and diagnostic toolsTrends Biotechnol201432526327024698358
   PubMed Web of Science ®Google Scholar
• SiontorouCGNanobodies as novel agents for disease diagnosis and therapyInt J Nanomedicine201384215422724204148
   PubMed Web of Science ®Google Scholar
• SaerensDMuyldermansSSingle Domain Antibodies: Methods and ProtocolsTotowa, NJHumana Press2012
   Google Scholar
• ZielonkaSEmptingMGrzeschikJKonningDBarelleCJKolmarHStructural insights and biomedical potential of IgNAR scaffolds from sharksMAbs201571152525523873
   PubMed Web of Science ®Google Scholar
• FlajnikMFKasaharaMOrigin and evolution of the adaptive immune system: genetic events and selective pressuresNat Rev Genet2010111475919997068
   PubMed Web of Science ®Google Scholar
• ShaoCYSecombesCJPorterAJRapid isolation of IgNAR variable single-domain antibody fragments from a shark synthetic libraryMol Immunol200744465666516500706
   PubMedGoogle Scholar
• LiuJLAndersonGPDelehantyJBBaumannRHayhurstAGoldmanERSelection of cholera toxin specific IgNAR single-domain antibodies from a naive shark libraryMol Immunol20074471775178317007931
   PubMed Web of Science ®Google Scholar
• DooleyHFlajnikMFAntibody repertoire development in cartilaginous fishDev Comp Immunol2006301–2435616146649
   PubMedGoogle Scholar
• MuyldermansSBaralTNRetamozzoVCCamelid immunoglobulins and nanobody technologyVet Immunol Immunopathol20091281–317818319026455
   PubMed Web of Science ®Google Scholar
• HelmaJCardosoMCMuyldermansSLeonhardtHNanobodies and recombinant binders in cell biologyJ Cell Biol2015209563364426056137
   PubMed Web of Science ®Google Scholar
• MuyldermansSAtarhouchTSaldanhaJBarbosaJAHamersRSequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chainsProtein Eng199479112911357831284
   PubMedGoogle Scholar
• VuKBGhahroudiMAWynsLMuyldermansSComparison of llama VH sequences from conventional and heavy chain antibodiesMol Immunol19973416–17112111319566760
   PubMed Web of Science ®Google Scholar
• HarmsenMMRuulsRCNijmanIJNiewoldTAFrenkenLGJde GeusBLlama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence featuresMol Immunol2000371057959011163394
   PubMed Web of Science ®Google Scholar
• MaassDRSepulvedaJPernthanerAShoemakerCBAlpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs)J Immunol Methods20073241–2132517568607
   PubMedGoogle Scholar
• GovaertJPellisMDeschachtNDual beneficial effect of inter-loop disulfide bond for single domain antibody fragmentsJ Biol Chem201228731970197922128183
   PubMed Web of Science ®Google Scholar
• CriscitielloMFSaltisMFlajnikMFAn evolutionarily mobile antigen receptor variable region gene: doubly rearranging NAR-TcR genes in sharksProc Natl Acad Sci U S A2006103135036504116549799
   PubMed Web of Science ®Google Scholar
• LiuJLAndersonGPGoldmanERIsolation of anti-toxin single domain antibodies from a semi-synthetic spiny dogfish shark display libraryBMC Biotechnol20077788718021450
   PubMed Web of Science ®Google Scholar
• StanfieldRLDooleyHVerdinoPFlajnikMFWilsonIAMaturation of shark single-domain (IgNAR) antibodies: evidence for induced-fit bindingJ Mol Biol2007367235837217258766
   PubMed Web of Science ®Google Scholar
• StanfieldRLDooleyHFlajnikMFWilsonIACrystal structure of a shark single-domain antibody V region in complex with lysozymeScience200430556911770177315319492
   PubMed Web of Science ®Google Scholar
• DesmyterATransueTRGhahroudiMACrystal structure of a camel single-domain VH antibody fragment in complex with lysozymeNat Struct Biol1996398038118784355
   PubMedGoogle Scholar
• De GenstESilenceKDecanniereKMolecular basis for the preferential cleft recognition by dromedary heavy-chain antibodiesProc Natl Acad Sci U S A2006103124586459116537393
   PubMed Web of Science ®Google Scholar
• DesmyterADecanniereKMuyldermansSWynsLAntigen specificity and high affinity binding provided by one single loop of a camel single-domain antibodyJ Biol Chem200127628262852629011342547
   PubMed Web of Science ®Google Scholar
• SpinelliSTegoniMFrenkenLvan VlietCCambillauCLateral recognition of a dye hapten by a llama VHH domainJ Mol Biol2001311112312911469862
   PubMed Web of Science ®Google Scholar
• SpinelliSFrenkenLGHermansPCamelid heavy-chain variable domains provide efficient combining sites to haptensBiochemistry20003961217122210684599
   PubMed Web of Science ®Google Scholar
• HolligerPHudsonPJEngineered antibody fragments and the rise of single domainsNat Biotechnol20052391126113616151406
   PubMed Web of Science ®Google Scholar
• GoldmanERAndersonGPLiuJLFacile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama libraryAnal Chem200678248245825517165813
   PubMed Web of Science ®Google Scholar
• HuangLMuyldermansSSaerensDNanobodies(R): proficient tools in diagnosticsExpert Rev Mol Diagn201010677778520843201
   PubMed Web of Science ®Google Scholar
• VaneyckenIDevoogdtNVan GassenNPreclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancerFASEB J20112572433244621478264
   PubMed Web of Science ®Google Scholar
• HuangLGainkamLOTCaveliersVSPECT imaging with Tc-99m-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expressionMol Imaging Biol200810316717518297364
   PubMed Web of Science ®Google Scholar
• De GroeveKDeschachtNDe KoninckCNanobodies as tools for in vivo imaging of specific immune cell typesJ Nucl Med201051578278920395332
   PubMed Web of Science ®Google Scholar
• JongedijkEVerheesenPinventorAgroSavfe NV, assignee (Gent, BE)Specific delivery of agrochemicalsUS patent85980811232013
   Google Scholar
• VerheesenPJongedijkEinventorsAgroSavfe NV, assignee (Gent, BE)Insect binding antibodiesUS patent201302242268292013
   Google Scholar
• HarmsenMMDe HaardHJProperties, production, and applications of camelid single-domain antibody fragmentsAppl Microbiol Biotechnol2007771132217704915
   PubMed Web of Science ®Google Scholar
• WesolowskiJAlzogarayVReyeltJSingle domain antibodies: promising experimental and therapeutic tools in infection and immunityMed Microbiol Immunol2009198315717419529959
   PubMed Web of Science ®Google Scholar
• de MarcoABiotechnological applications of recombinant single-domain antibody fragmentsMicrob Cell Fact2011104421658216
   PubMedGoogle Scholar
• DmitrievOYLutsenkoSMuyldermansSNanobodies as probes for protein dynamics in vitro and in cellsJ Biol Chem201629183767377526677230
   PubMedGoogle Scholar
• KloosterRMaassenBTHStamJCImproved anti-IgG and HSA affinity ligands: clinical application of VHH antibody technologyJ Immunol Methods20073241–211217570391
   PubMedGoogle Scholar
• De GenstEJGuilliamsTWellensJStructure and properties of a complex of alpha-synuclein and a single-domain camelid antibodyJ Mol Biol2010402232634320620148
   PubMedGoogle Scholar
• KloosterREmanMRle DucQSelection and characterization of KDEL-specific VHH antibody fragments and their application in the study of ER resident protein expressionJ Immunol Methods20093421–211219041652
   PubMed Web of Science ®Google Scholar
• Nguyen-DucTPeetersEMuyldermansSCharlierDHassanzadeh-GhassabehGNanobody(R)-based chromatin immunoprecipitation/micro-array analysis for genome-wide identification of transcription factor DNA binding sitesNucleic Acids Res2013415e5923275538
   PubMedGoogle Scholar
• PollithyARomerTLangCMagnetosome expression of functional camelid antibody fragments (nanobodies) in Magnetospirillum gryphiswaldenseAppl Environ Microbiol201177176165617121764974
   PubMed Web of Science ®Google Scholar
• BaranovaEFronzesRGarcia-PinoASbsB structure and lattice reconstruction unveil Ca2+ triggered S-layer assemblyNature2012487740511912222722836
   PubMedGoogle Scholar
• RasmussenSGFChoiH-JFungJJStructure of a nanobody- stabilized active state of the beta(2) adrenoceptorNature2011469732917518021228869
   PubMed Web of Science ®Google Scholar
• LorisRMarianovskyILahJCrystal structure of the intrinsically flexible addiction antidote MazEJ Biol Chem200327830282522825712743116
   PubMedGoogle Scholar
• KoideSEngineering of recombinant crystallization chaperonesCurr Opin Struct Biol200919444945719477632
   PubMedGoogle Scholar
• PardonELaeremansTTriestSA general protocol for the generation of nanobodies for structural biologyNat Protoc20149367469324577359
   PubMed Web of Science ®Google Scholar
• DomanskaKVanderhaegenSSrinivasanVAtomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta 2-microglobulin variantProc Natl Acad Sci U S A201110841314131921220305
   PubMedGoogle Scholar
• AbskharonRNNGiachinGWohlkonigAProbing the N-terminal beta-sheet conversion in the crystal structure of the human prion protein bound to a nanobodyJACS20141363937944
   PubMed Web of Science ®Google Scholar
• LamAYPardonEKorotkovKVHolWGJSteyaertJNanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificusJ Struct Biol2009166181519118632
   PubMedGoogle Scholar
• KorotkovKVPardonESteyaertJHolWGJCrystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobodyStructure200917225526519217396
   PubMedGoogle Scholar
• CaussinusEKancaOAffolterMFluorescent fusion protein knockout mediated by anti-GFP nanobodyNat Struct Mol Biol201119111712122157958
   PubMedGoogle Scholar
• CaussinusEKancaOAffolterMProtein knockouts in living eukaryotes using deGradFP and green fluorescent protein fusion targetsCurr Protoc Protein Sci20137373 Unit30.2
   Google Scholar
• TangJCYSzikraTKozorovitskiyYA nanobody-based system using fluorescent proteins as scaffolds for cell-specific gene manipulationCell2013154492893923953120
   PubMedGoogle Scholar
• RothbauerUZolghadrKTillibSTargeting and tracing antigens in live cells with fluorescent nanobodiesNat Methods200631188788917060912
   PubMed Web of Science ®Google Scholar
• OlichonASurreyTSelection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coliJ Biol Chem200728250363143632017921141
   PubMedGoogle Scholar
• ZolghadrKGregorJLeonhardtHRothbauerUCase study on live cell apoptosis-assay using lamin-chromobody cell-lines for high-content analysisMethods Mol Biol201291156957522886277
   PubMedGoogle Scholar
• HelmaJSchmidthalsKLuxVDirect and dynamic detection of HIV-1 in living cellsPLoS One2012711E5002623209635
   PubMedGoogle Scholar
• RiesJKaplanCPlatonovaEEghlidiHEwersHA simple, versatile method for GFP-based super-resolution microscopy via nanobodiesNat Methods20129658258422543348
   PubMed Web of Science ®Google Scholar
• LeducCSiSGautierJA highly specific gold nanoprobe for live-cell single-molecule imagingNano Lett20131341489149423458263
   PubMedGoogle Scholar
• HerceHDDengWHelmaJLeonhardtHCardosoMCVisualization and targeted disruption of protein interactions in living cellsNat Commun20134266024154492
   PubMed Web of Science ®Google Scholar
• TanakaTSewellHWatersSPhillipsSEVRabbittsTHSingle domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domainJ Biol Chem201128653707371620980262
   PubMedGoogle Scholar
• Perez-MartinezDTanakaTRabbittsTHIntracellular antibodies and cancer: new technologies offer therapeutic opportunitiesBioessays201032758959820544739
   PubMedGoogle Scholar
• KirchhoferAHelmaJSchmidthalsKModulation of protein properties in living cells using nanobodiesNat Struct Mol Biol201017113313820010839
   PubMed Web of Science ®Google Scholar
• RomerTLeonhardtHRothbauerUEngineering antibodies and proteins for molecular in vivo imagingCurr Opin Biotechnol201122688288721708456
   PubMed Web of Science ®Google Scholar
• SchmidthalsKHelmaJZolghadrKRothbauerULeonhardtHNovel antibody derivatives for proteome and high-content analysisAnal Bioanal Chem201039783203320820372881
   PubMed Web of Science ®Google Scholar
• RothbauerUZolghadrKMuyldermansSSchepersACardosoMCLeonhardtHA versatile nanotrap for biochemical and functional studies with fluorescent fusion proteinsMol Cell Proteomics20087228228917951627
   PubMed Web of Science ®Google Scholar
• SchornackSFuchsRHuitemaERothbauerULipkaVKamounSProtein mislocalization in plant cells using a GFP-binding chromobodyPlant J200960474475419686537
   PubMedGoogle Scholar
• VaneyckenID’HuyvetterMHernotSImmuno-imaging using nanobodiesCurr Opin Biotechnol201122687788121726996
   PubMed Web of Science ®Google Scholar
• BroisatAHernotSToczekJNanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesionsCirc Res2012110792793722461363
   PubMed Web of Science ®Google Scholar
• VosjanMJWDPerkLRRooversRCFacile labelling of an anti-epidermal growth factor receptor nanobody with Ga-68 via a novel bifunctional desferal chelate for immuno-PETEur J Nucl Med Mol Imaging201138475376321210114
   PubMed Web of Science ®Google Scholar
• MovahediKSchoonoogheSLaouiDNanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophagesCancer Res201272164165417722719068
   PubMed Web of Science ®Google Scholar
• KijankaMWarndersF-JEl KhattabiMRapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgeryEur J Nucl Med Mol Imaging201340111718172923778558
   PubMedGoogle Scholar
• OliveiraSvan DongenGAMSStigter-van WalsumMRapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobodyMol Imaging2012111334622418026
   PubMed Web of Science ®Google Scholar
• SaerensDFrederixFReekmansGEngineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensingAnal Chem200577237547755516316161
   PubMed Web of Science ®Google Scholar
• HarmsenMMFijtenHPDImproved functional immobilization of llama single-domain antibody fragments to polystyrene surfaces using small peptidesJ Immunoassay Immunochem201233323425122738648
   PubMed Web of Science ®Google Scholar
• SaerensDHuangLBonroyKMuyldermansSAntibody fragments as probe in biosensor developmentSensors20088846694686
   PubMed Web of Science ®Google Scholar
• Even-DesrumeauxKBatyDChamesPStrong and oriented immobilization of single domain antibodies from crude bacterial lysates for high-throughput compatible cost-effective antibody array generationMol Biosyst20106112241224820859568
   PubMedGoogle Scholar
• AbbadyAQAl-DaoudeAAl-MaririAZarkawiMMuyldermansSChaperonin GroEL a Brucella immunodominant antigen identified using nanobody and MALDI-TOF-MS technologiesVet Immunol Immunopathol20121463–425426322472910
   PubMedGoogle Scholar
• DeckersNSaerensDKanobanaKNanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosisInt J Parasitol200939562563319041315
   PubMedGoogle Scholar
• SaerensDStijlemansBBaralTNParallel selection of multiple anti-infectome nanobodies without access to purified antigensJ Immunol Methods20083291–213815017996887
   PubMed Web of Science ®Google Scholar
• HabibISmolarekDHattabCVHH (nanobody) directed against human glycophorin A: a tool for autologous red cell agglutination assaysAnal Biochem20134381828923541519
   PubMedGoogle Scholar
• HmilaISaerensDBen AbderrazekRA bispecific nanobody to provide full protection against lethal scorpion envenomingFASEB J20102493479348920410443
   PubMed Web of Science ®Google Scholar
• HussackGArbabi-GhahroudiMvan FaassenHNeutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domainJ Biol Chem2011286118961897621216961
   PubMed Web of Science ®Google Scholar
• StewartCSMacKenzieCRHallJCIsolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naive phage display library: preliminary findings for antivenom developmentToxicon200749569970917257638
   PubMedGoogle Scholar
• CookDANSamarasekaraCLWagstaffSCKinneJWerneryUHarrisonRAAnalysis of camelid IgG for antivenom development: immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatmentToxicon201056459660320547172
   PubMed Web of Science ®Google Scholar
• HarrisonRAHassonSSHarmsenMLaingGDConrathKTheakstonRDGNeutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid seraToxicon200647336436816359717
   PubMed Web of Science ®Google Scholar
• PantNMarcotteHHermansPLactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrheaFuture Microbiol20116558359321585264
   PubMed Web of Science ®Google Scholar
• KrugerCHultbergAMarcotteHTherapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental cariesAppl Microbiol Biotechnol200672473273716636830
   PubMedGoogle Scholar
• HarmsenMMFijtenHPDEngelBDekkerAEblePLPassive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigsVaccine200927131904191119368770
   PubMedGoogle Scholar
• StrokappeNSzynolAAasa-ChapmanMLlama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and CPLoS One201273e3329822438910
   PubMedGoogle Scholar
• KohWWLSteffensenSGonzalez-PajueloMGeneration of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1J Biol Chem201028525191161912420400507
   PubMedGoogle Scholar
• HinzAHulsikDLForsmanACrystal structure of the neutralizing llama V-HH D7 and its mode of HIV-1 gp120 interactionPLoS One201055e1048220463957
   PubMedGoogle Scholar
• De HaardHJWBezemerSLedeboerAMLlama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infectionJ Bacteriol2005187134531454115968064
   PubMed Web of Science ®Google Scholar
• IbanezLIDe FiletteMHultbergANanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infectionJ Infect Dis201120381063107221450996
   PubMed Web of Science ®Google Scholar
• StijlemansBConrathKCortez-RetamozoVEfficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies – African trypanosomes as paradigmJ Biol Chem200427921256126114527957
   PubMed Web of Science ®Google Scholar
• Koch-NolteFReyeltJSchossowBSingle domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivoFASEB J200721133490349817575259
   PubMed Web of Science ®Google Scholar
• Camacho-VillegasTMata-GonzalezTPaniagua-SolisJSanchezELiceaAHuman TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic useMAbs201351808523221782
   PubMed Web of Science ®Google Scholar
• BojalilRMata-GonzalezMTSanchez-MunozFAnti-tumor necrosis factor (V)NAR single domains reduce lethality and regulate underlying inflammatory response in a murine model of endotoxic shockBMC Immunol2013141723548047
   PubMed Web of Science ®Google Scholar
• Van RoyMVerverkenCBeirnaertEThe preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritisArthritis Res Ther20151713525994180
   PubMed Web of Science ®Google Scholar
• HolzJ-BThe TITAN trial – assessing the efficacy and safety of an anti-von Willebrand factor nanobody in patients with acquired thrombotic thrombocytopenic purpuraTrans Apher Sci2012463343346
   PubMed Web of Science ®Google Scholar
• KontermannREStrategies for extended serum half-life of protein therapeuticsCurr Opin Biotechnol201122686887621862310
   PubMed Web of Science ®Google Scholar
• LiTBourgeoisJ-PCelliSCell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imagingFASEB J201226103969397922730440
   PubMed Web of Science ®Google Scholar
• PerruchiniCPecorariFBourgeoisJ-PDuyckaertsCRougeonFLafayePLlama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodiesActa Neuropathol2009118568569519597828
   PubMedGoogle Scholar
• IqbalUTrojahnUAlbaghdadiHKinetic analysis of novel mono-and multivalent VHH-fragments and their application for molecular imaging of brain tumoursBr J Pharmacol201016041016102820590596
   PubMed Web of Science ®Google Scholar
• EmmersonCDvan der VlistEJBraamMREnhancement of polymeric immunoglobulin receptor transcytosis by biparatopic VHHPLoS One2011610e2629922022593
   PubMed Web of Science ®Google Scholar
• Van de BroekBDevoogdtND’HollanderASpecific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapyACS Nano2011564319432821609027
   PubMed Web of Science ®Google Scholar
• JoblingSAJarmanCTehMMHolmbergNBlakeCVerhoeyenMEImmunomodulation of enzyme function in plants by single-domain antibody fragmentsNat Biotechnol2003211778012483224
   PubMed Web of Science ®Google Scholar
• VerheesenPDe JongheCinventorAgroSavfe NV, assignee (Gent, BE)Manufacturing of specifically targeting microcapsulesUS patent201500875173262015
   Google Scholar
• LadensonRCCrimminsDLLandtYLadensonJHIsolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragmentAnal Chem200678134501450816808459
   PubMed Web of Science ®Google Scholar
• TurnerKBAlvesNJMedintzILWalperSAImproving the targeting of therapeutics with single-domain antibodiesExpert Opin Drug Del2016134561570
   PubMed Web of Science ®Google Scholar
• KijankaMDorresteijnBOliveiraSHenegouwenPNanobody-based cancer therapy of solid tumorsNanomedicine (Lond)201510116117425597775
   PubMed Web of Science ®Google Scholar